1 - 10 out of 162Page size: 10
  1. 2023

  2. Drug-tolerant detection of anti-drug antibodies in an antigen-binding assay using europium chelate fluorescence

    van Strien, J., Dijk, L., Atiqi, S., Schouten, R., Bloem, K., Wolbink, G. J., Loeff, F. & Rispens, T., 1 Mar 2023, In: Journal of immunological methods. 514, 113436.

    Research output: Contribution to journal › Article › Academic › peer-review

  3. Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations

    the T2B! immunity against SARS-CoV-2 study group, 1 Feb 2023, In: Journal of autoimmunity. 135, 102984.

    Research output: Contribution to journal › Article › Academic › peer-review

  4. Case report: Pharmacokinetics of pembrolizumab in a patient with stage IV non?small cell lung cancer after a single 200 mg administration

    de Vries, F., Smit, A. A. J., Wolbink, G., de Vries, A., Loeff, F. C. & Franssen, E. J. F., 11 Jan 2023, In: Frontiers in oncology. 12, 960116.

    Research output: Contribution to journal › Article › Academic › peer-review

  5. Ocrelizumab Concentration Is a Good Predictor of SARS-CoV-2 Vaccination Response in Patients with Multiple Sclerosis

    the T2B! immunity against SARS-CoV-2 study group, Jan 2023, In: Annals of neurology. 93, 1, p. 103-108 6 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  6. EULAR study group on 'MHC-I-opathy': identifying disease-overarching mechanisms across disciplines and borders

    EULAR studygroup MHC-I-opathies, 2023, (E-pub ahead of print) In: Annals of the rheumatic diseases. 222852.

    Research output: Contribution to journal › Review article › Academic › peer-review

  7. Persistence of seroconversion at 6 months following primary immunisation in patients with immune-mediated inflammatory diseases

    Wieske, L., Stalman, E. W., van Dam, P. J. K., Kummer, L. Y., Steenhuis, M., van Kempen, Z. L. E., Killestein, J., Volkers, A. G., Tas, S. W., Boekel, L., Wolbink, G., van der Kooi, A., Raaphorst, J., Löwenberg, M., Takkenberg, B., D'Haens, G. R. A. M., Spuls, P. I., Bekkenk, M. W., Musters, A. H., Post, N. F., & 38 othersBosma, A. L., Hilhorst, M. L., Vegting, Y., Bemelman, F. J., Voskuyl, A., Broens, B., Parra Sanchez, A., van Els, C. C. A. C. M., Wit, J. D., Rutgers, A., de Leeuw, K., Horváth, B., Verschuuren, J. J. G. M., Ruiter, A. M., van Ouwerkerk, L., van der Woude, D., Allaart, C. F., Teng, Y. K. O., van Paassen, P., Busch, M. H., Jallah, P. B. P., Brusse, E., van Doorn, P. A., Baars, A. E., Hijnen, D., Schreurs, C. R. G., van der Pol, W. L., Goedee, H. S., Keijzer, S., Keijser, J., Cristianawati, O., ten Brinke, A., Verstegen, N. J. M., Zwinderman, K. A. H., van Ham, S. M., Kuijpers, T. W., Rispens, T. & Eftimov, F., 2023, (E-pub ahead of print) In: Annals of the rheumatic diseases. ard-2022-223464.

    Research output: Contribution to journal › Review article › Academic › peer-review

  8. 2022

  9. Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases

    Wieske, L., Kummer, L. Y. L., van Dam, K. P. J., Stalman, E. W., van der Kooi, A. J., Raaphorst, J., Löwenberg, M., Takkenberg, R. B., Volkers, A. G., D'Haens, G. R. A. M., Tas, S. W., Spuls, P. I., Bekkenk, M. W., Musters, A. H., Post, N. F., Bosma, A. L., Hilhorst, M. L., Vegting, Y., Bemelman, F. J., Killestein, J., & 34 othersvan Kempen, Z. L. E., Voskuyl, A. E., Broens, B., Sanchez, A. P., Wolbink, G., Boekel, L., Rutgers, A., de Leeuw, K., Horváth, B., Verschuuren, J. J. G. M., Ruiter, A. M., van Ouwerkerk, L., van der Woude, D., Allaart, C. F., Teng, Y. K. O., van Paassen, P., Busch, M. H., Jallah, B. P., Brusse, E., van Doorn, P. A., Baars, A. E., Hijnen, D., Schreurs, C. R. G., van der Pol, W. L., Goedee, H. S., Steenhuis, M., Rispens, T., ten Brinke, A., Verstegen, N. J. M., Zwinderman, K. A. H., van Ham, S. M., T2B! immunity against SARS-CoV-2 study group, Kuijpers, T. W. & Eftimov, F., Dec 2022, In: BMC medicine. 20, 1, p. 100 100.

    Research output: Contribution to journal › Article › Academic › peer-review

  10. Multi-ancestry genome-wide association analyses identify novel genetic mechanisms in rheumatoid arthritis

    Ishigaki, K., Sakaue, S., Terao, C., Luo, Y., Sonehara, K., Yamaguchi, K., Amariuta, T., Too, C. L., Laufer, V. A., Scott, I. C., Viatte, S., Takahashi, M., Ohmura, K., Murasawa, A., Hashimoto, M., Ito, H., Hammoudeh, M., Emadi, S. A., Masri, B. K., Halabi, H., & 71 othersBadsha, H., Uthman, I. W., Wu, X., Lin, L., Li, T., Plant, D., Barton, A., Orozco, G., Verstappen, S. M. M., Bowes, J., MacGregor, A. J., Honda, S., Koido, M., Tomizuka, K., Kamatani, Y., Tanaka, H., Tanaka, E., Suzuki, A., Maeda, Y., Yamamoto, K., Miyawaki, S., Xie, G., Zhang, J., Amos, C. I., Keystone, E., Wolbink, G., van der Horst-Bruinsma, I., Cui, J., Liao, K. P., Carroll, R. J., Lee, H-S., Bang, S-Y., Siminovitch, K. A., de Vries, N., Alfredsson, L., Rantapää-Dahlqvist, S., Karlson, E. W., Bae, S-C., Kimberly, R. P., Edberg, J. C., Mariette, X., Huizinga, T., Dieudé, P., Schneider, M., Kerick, M., Denny, J. C., Matsuda, K., Matsuo, K., Mimori, T., Matsuda, F., Fujio, K., Tanaka, Y., Kumanogoh, A., Traylor, M., Lewis, C. M., Eyre, S., Xu, H., Saxena, R., Arayssi, T., Kochi, Y., Ikari, K., Harigai, M., Gregersen, P. K., Yamamoto, K., Louis Bridges, S., Padyukov, L., Martin, J., Klareskog, L., The BioBank Japan Project, Okada, Y. & Raychaudhuri, S., 1 Nov 2022, In: Nature genetics. 54, 11, p. 1640-1651 12 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  11. SARS-CoV-2 breakthrough infections in patients with immune-mediated inflammatory diseases during the omicron dominant period

    Boekel, L., Besten, Y. R., Hooijberg, F., Wartena, R., Steenhuis, M., Vogelzang, E., Leeuw, M., Atiqi, S., Tas, S. W., Lems, W. F., van Ham, S. M., Eftimov, F., Stalman, E. W., Wieske, L., Kuijpers, T. W., Voskuyl, A. E., van Vollenhoven, R. F., Gerritsen, M., Krieckaert, C., Rispens, T., & 3 othersBoers, M., Nurmohamed, M. T. & Wolbink, G., 1 Nov 2022, In: The Lancet Rheumatology. 4, 11, p. e747-e750

    Research output: Contribution to journal › Comment/Letter to the editor › Academic

  12. Breakthrough infections with the SARS-CoV-2 omicron (B.1.1.529) variant in patients with immune-mediated inflammatory diseases

    Stalman, E. W., Wieske, L., van Dam, K. P. J., Kummer, L. Y., van Kempen, Z. L. E., Killestein, J., Volkers, A. G., Tas, S. W., Boekel, L., Wolbink, G. J., van der Kooi, A. J., Raaphorst, J., Löwenberg, M., Takkenberg, R. B., D'Haens, G. R. A. M., Spuls, P. I., Bekkenk, M. W., Musters, A. H., Post, N. F., Bosma, A. L., & 39 othersHilhorst, M. L., Vegting, Y., Bemelman, F. J., Voskuyl, A. E., Broens, B., Parra Sanchez, A., van Els, C. C. A. C. M., Wit, J. D., Rutgers, A., de Leeuw, K., Horváth, B., Verschuuren, J. J. G. M., Ruiter, A. M., van Ouwerkerk, L., van der Woude, D., Allaart, C. F., Teng, O. Y. K., van Paassen, P., Busch, M. H., Jallah, P. B. P., Brusse, E., van Doorn, P. A., Baars, A. E., Hijnen, D. J., Schreurs, C. R. G., van der Pol, W. L., Goedee, H. S., Steenhuis, M., Keijzer, S., Keijser, J. B. D., Boogaard, A., Cristianawati, O., ten Brinke, A., Verstegen, N. J. M., Zwinderman, K. A. H., Rispens, T., van Ham, S. M., Kuijpers, T. W. & Eftimov, F., 5 Sept 2022, In: Annals of the rheumatic diseases. 81, 12, p. 1757-1766 10 p., 222904.

    Research output: Contribution to journal › Article › Academic › peer-review

Previous 1 2 3 4 5 6 7 8 ...17 Next

ID: 4526279